• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology.

作者信息

Bloch Sara Brandi, Larsen Michael

出版信息

Acta Ophthalmol. 2015 Mar;93(2):103-4. doi: 10.1111/aos.12680.

DOI:10.1111/aos.12680
PMID:25688486
Abstract
摘要

相似文献

1
Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology.转化性公共卫生保健视角：玻璃体内注射治疗新生血管性年龄相关性黄斑变性彻底改变了临床眼科。
Acta Ophthalmol. 2015 Mar;93(2):103-4. doi: 10.1111/aos.12680.
2
Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting.在医院环境中，主要由实习医生和护士进行的38503次玻璃体内注射雷珠单抗的安全性研究。
Acta Ophthalmol. 2015 Mar;93(2):122-5. doi: 10.1111/aos.12589. Epub 2014 Nov 17.
3
Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System.新生血管性年龄相关性黄斑变性的创新：布罗珠单抗、阿比西帕及端口递送系统的考量
Ophthalmic Surg Lasers Imaging Retina. 2018 Dec 1;49(12):913-917. doi: 10.3928/23258160-20181203-01.
4
Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.玻璃体内注射贝伐单抗治疗视力低于20/200的晚期新生血管性年龄相关性黄斑变性
Arch Ophthalmol. 2012 Jul;130(7):934-5. doi: 10.1001/archophthalmol.2011.2617.
5
Two Year SAVE Outcomes: 2.0 mg ranibizumab for recalcitrant neovascular AMD.两年的“挽救视力”研究结果：2.0毫克雷珠单抗用于治疗顽固性新生血管性年龄相关性黄斑变性。
Ophthalmology. 2013 Sep;120(9):1945-6.e1. doi: 10.1016/j.ophtha.2013.06.030.
6
Incidence of Charles Bonnet syndrome after intravitreal bevacizumab injection in neovascular age-related macular degeneration.玻璃体内注射贝伐单抗治疗新生血管性年龄相关性黄斑变性后查尔斯·博内综合征的发生率
Acta Ophthalmol. 2012 Dec;90(8):e647-8. doi: 10.1111/j.1755-3768.2012.02421.x. Epub 2012 Apr 10.
7
Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age-related macular degeneration.玻璃体内雷珠单抗治疗新生血管性年龄相关性黄斑变性后视网膜小静脉管径扩张。
Clin Exp Ophthalmol. 2012 Jan-Feb;40(1):59-66. doi: 10.1111/j.1442-9071.2011.02613.x. Epub 2011 Aug 18.
8
Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration.玻璃体内注射贝伐单抗对新生血管性年龄相关性黄斑变性患眼及对侧未注射眼球后血流的影响。
Retina. 2012 May;32(5):967-71. doi: 10.1097/IAE.0b013e31822c28d6.
9
Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.用于治疗新生血管性年龄相关性黄斑变性的贝伐单抗持续给药方案：基线特征的重要性
Retina. 2014 May;34(5):846-52. doi: 10.1097/IAE.0000000000000033.
10
Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.基于新生血管性年龄相关性黄斑变性初始稳定后视力变化的抗血管内皮生长因子治疗的再治疗：3 年随访结果。
Retina. 2012 Sep;32(8):1471-9. doi: 10.1097/IAE.0b013e318236e805.

引用本文的文献

1
Ultrasound Biomicroscopy of Patients With Hemorrhagic Complications Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection.玻璃体内注射抗血管内皮生长因子后出血性并发症患者的超声生物显微镜检查
J Vitreoretin Dis. 2025 Aug 28:24741264251364011. doi: 10.1177/24741264251364011.
2
Systemic adverse events and all-cause mortality following same-session bilateral intravitreal anti-VEGF injections: a systematic review.同一次双侧玻璃体内抗血管内皮生长因子注射后的全身不良事件和全因死亡率：系统评价。
Graefes Arch Clin Exp Ophthalmol. 2024 Aug;262(8):2355-2364. doi: 10.1007/s00417-023-06368-8. Epub 2024 Jan 9.
3
Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology.
糖尿病性黄斑水肿的管理：阿联酋眼科学会指南
Ophthalmol Ther. 2022 Oct;11(5):1937-1950. doi: 10.1007/s40123-022-00547-2. Epub 2022 Jul 27.
4
Eye care infrastructure and human resources for managing diabetic retinopathy in India: The India 11-city 9-state study.印度糖尿病视网膜病变管理的眼保健基础设施及人力资源：印度11个城市9个邦的研究
Indian J Endocrinol Metab. 2016 Apr;20(Suppl 1):S3-S10. doi: 10.4103/2230-8210.179768.